Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach

There is a significant increase in the occurrence of carbapenem-resistant Klebsiella pneumoniae (CRKP) blood-stream infections among identified carriers of CRKP, especially in critically ill patients dwelling in intensive care units (ICU). This is emerging as a particularly critical problem due to increasing resistance and mortality among ICU patients in developed as well as developing countries (1).